J Korean Foot Ankle Soc.  2024 Jun;28(2):55-59. 10.14193/jkfas.2024.28.2.55.

Treatment and Prognosis for Tumors of the Foot and Ankle

• Han SS
• Kim JI
• Goh TS
• Woo SH
• Kim JY

• KMID: 2556554
• DOI: http://doi.org/10.14193/jkfas.2024.28.2.55

Abstract

Purpose
Tumors of the foot and ankle account for approximately 3%~5% of all musculoskeletal tumors, and accurate diagnosis is often delayed due to their rare prevalence. Therefore, the authors aimed to analyze the incidence, treatment methods, and prognostic factors of foot and ankle tumors treated at the authors’ hospital.
Materials and Methods
A retrospective single-center study examined 342 patients treated for foot and ankle tumors at the authors’ hospital from January 2011 to February 2022. Data were collected from the electronic medical records (EMR) and picture archiving and communication systems (PACS). The information analyzed included gender, age, follow-up period, diagnosis, tumor occurrence and recurrence, treatment, and clinical outcomes.
Results
Most cases (93.3%) were benign, but 6.7% were malignant. The main treatment for malignant tumors was surgical resection (91.3%). Approximately 53.1% of benign tumors and 91.3% of malignant tumors were treated with surgery, and two of the malignant tumors that did not undergo surgery had metastatic cancer. After surgery, 8.2% of benign lesions and 19.0% of malignant lesions recurred, and 9.5% of the patients with malignant tumors died after surgery.
Conclusion
Most foot and ankle tumors are benign tumors, and the prognosis is not poor if treated properly, but most malignant tumors often require amputation. In some cases, however, amputation can be avoided with a combination of chemotherapy and radiation therapy.

Keyword

Foot; Ankle; Tumor-like lesion; Benign tumor; Malignant tumor

Figure

• 

  Figure 1 (A) Coronal view magnetic resonance imaging foot right (contrast-enhanced)-fat-suppressed T2-weighted imaging. (B) Photograph of the marginal excision of tumor. (C) After postoperative radiation therapy (no evidence of recurrence, 3 years follow-up).

• 

  Figure 2 (A) Coronal view magnetic resonance imaging foot left (contrast-enhanced)-T2-weighted imaging. (B) Intraoperative photograph. (C) Photograph of the marginal excision of tumor. (D) After postoperative radiation therapy and chemotherapy (no evidence of recurrence, 3 years follow-up).

Reference

1. Rammelt S, Fritzsche H, Hofbauer C, Schaser KD. 2020; Malignant tumours of the foot and ankle. Foot Ankle Surg. 26:363–70. doi: 10.1016/j.fas.2019.05.005. DOI: 10.1016/j.fas.2019.05.005. PMID: 31126797.

2. Chou LB, Ho YY, Malawer MM. 2009; Tumors of the foot and ankle: experience with 153 cases. Foot Ankle Int. 30:836–41. doi: 10.3113/FAI.2009.0836. DOI: 10.3113/FAI.2009.0836. PMID: 19755066.

3. Ruggieri P, Angelini A, Jorge FD, Maraldi M, Giannini S. 2014; Review of foot tumors seen in a university tumor institute. J Foot Ankle Surg. 53:282–5. doi: 10.1053/j.jfas.2014.01.015. DOI: 10.1053/j.jfas.2014.01.015. PMID: 24751209.

4. Toepfer A, Harrasser N, Recker M, Lenze U, Pohlig F, Gerdesmeyer L, et al. 2018; Distribution patterns of foot and ankle tumors: a university tumor institute experience. BMC Cancer. 18:735. doi: 10.1186/s12885-018-4648-3. DOI: 10.1186/s12885-018-4648-3. PMID: 30001718. PMCID: PMC6043962.

5. Yang P, Evans S, Bali N, Ramasamy A, Evans R, Stevenson J, et al. 2017; Malignant bone tumours of the foot. Ann R Coll Surg Engl. 99:568–72. doi: 10.1308/rcsann.2017.0114. DOI: 10.1308/rcsann.2017.0114. PMID: 28853588. PMCID: PMC5697046.

6. Mascard E, Gaspar N, Brugières L, Glorion C, Pannier S, Gomez-Brouchet A. 2017; Malignant tumours of the foot and ankle. EFORT Open Rev. 2:261–71. doi: 10.1302/2058-5241.2.160078. DOI: 10.1302/2058-5241.2.160078. PMID: 28630763. PMCID: PMC5467685.

7. Karaca MO, Başarır K, Merter A, Acar E, Özbek EA, Özyıldıran M, et al. 2022; Malignant tumors of the foot and ankle. Foot Ankle Int. 43:1232–41. doi: 10.1177/10711007221097654. DOI: 10.1177/10711007221097654. PMID: 35695294. PMCID: PMC9465811.

8. Kransdorf MJ. 1995; Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol. 164:395–402. doi: 10.2214/ajr.164.2.7839977. DOI: 10.2214/ajr.164.2.7839977. PMID: 7839977.

9. Kransdorf MJ. 1995; Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 164:129–34. doi: 10.2214/ajr.164.1.7998525. DOI: 10.2214/ajr.164.1.7998525. PMID: 7998525.

10. Kinoshita G, Matsumoto M, Maruoka T, Shiraki T, Tsunemi K, Futani H, et al. 2002; Bone and soft tissue tumours of the foot: review of 83 cases. J Orthop Surg (Hong Kong). 10:173–8. doi: 10.1177/230949900201000212. DOI: 10.1177/230949900201000212. PMID: 12493931.

11. Hegazi TM, Aljamaan YM, Alghamdi SG, Alsaygh JS, Awary KB, Aladel FI, et al. 2023; Review of soft tissue masses of the foot and ankle: magnetic resonance imaging features. Saudi J Med Med Sci. 11:117–25. doi: 10.4103/sjmms.sjmms_66_22. DOI: 10.4103/sjmms.sjmms_66_22. PMID: 37252018. PMCID: PMC10211414.

12. Angelini A, Biz C, Cerchiaro M, Longhi V, Ruggieri P. 2023; Malignant bone and soft tissue lesions of the foot. J Clin Med. 12:3038. doi: 10.3390/jcm12083038. DOI: 10.3390/jcm12083038. PMID: 37109375. PMCID: PMC10146676.